{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:04:52Z","timestamp":1793228692720,"version":"4.5.0"},"reference-count":385,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.dld.2025.04.020","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T19:07:16Z","timestamp":1748632036000},"page":"1550-1577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG)"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-2894","authenticated-orcid":false,"given":"Edoardo Vincenzo","family":"Savarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigida","family":"Barberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-857X","authenticated-orcid":false,"given":"Carmelo","family":"Scarpignato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-1952","authenticated-orcid":false,"given":"Vincenzo","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9745-0726","authenticated-orcid":false,"given":"Giovanni","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9816-4171","authenticated-orcid":false,"given":"Luisa","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Bonazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"de Bortoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Di","family":"Sario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8080-8218","authenticated-orcid":false,"given":"Giuseppe","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzio","family":"Frazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9210-4186","authenticated-orcid":false,"given":"Giuseppe","family":"Galloro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5789-3813","authenticated-orcid":false,"given":"Luigi","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6026-5639","authenticated-orcid":false,"given":"Matteo","family":"Ghisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Londoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4507-8605","authenticated-orcid":false,"given":"Elisa","family":"Marabotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Meggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8189-2159","authenticated-orcid":false,"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mentore","family":"Ribolsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3344-927X","authenticated-orcid":false,"given":"Paolo","family":"Usai Satta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0559-4875","authenticated-orcid":false,"given":"Vincenzo","family":"Stanghellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8600-9003","authenticated-orcid":false,"given":"Cesare","family":"Tosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6985-5301","authenticated-orcid":false,"given":"Pierfrancesco","family":"Visaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1133-1502","authenticated-orcid":false,"given":"Fabiana","family":"Zingone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1467-1134","authenticated-orcid":false,"given":"Giovanni","family":"Sarnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2025.04.020_bib0001","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0002","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrgastro.2013.50","article-title":"NERD: an umbrella term including heterogeneous subpopulations","volume":"10","author":"Savarino","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2022.01.025","article-title":"AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review","volume":"20","author":"Yadlapati","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00287-w","article-title":"Gastro-oesophageal reflux disease","volume":"7","author":"Fass","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.dld.2025.04.020_bib0005","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/17474124.2019.1645593","article-title":"Updates in the field of non-esophageal gastroesophageal reflux disorder","volume":"13","author":"Ghisa","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0006","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00101212","article-title":"Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients","volume":"42","author":"Savarino","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.dld.2025.04.020_bib0007","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1572-0241.2005.41217.x","article-title":"Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease","volume":"100","author":"DeVault","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0008","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0140-6736(90)90287-F","article-title":"Symptoms in gastro-oesophageal reflux disease","volume":"335","author":"Klauser","year":"1990","journal-title":"The Lancet"},{"key":"10.1016\/j.dld.2025.04.020_bib0009","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ueg2.12061","article-title":"United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia","volume":"9","author":"Wauters","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.dld.2025.04.020_bib0010","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/ueg2.12289","article-title":"Worldwide prevalence and burden of gastroparesis-like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis","volume":"10","author":"Huang","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.dld.2025.04.020_bib0011","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000103879","article-title":"Functional Heartburn and Non-Erosive Reflux Disease","volume":"25","author":"Savarino","year":"2007","journal-title":"Digestive Diseases"},{"key":"10.1016\/j.dld.2025.04.020_bib0012","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/gut.2008.175810","article-title":"Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease","volume":"58","author":"Savarino","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0013","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3399\/bjgp21X717329","article-title":"The tapestry of reflux syndromes: translating new insight into clinical practice","volume":"71","author":"Kahrilas","year":"2021","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.dld.2025.04.020_bib0014","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s40265-013-0101-8","article-title":"Extra-Esophageal Manifestations of Gastroesophageal Reflux Disease: Diagnosis and Treatment","volume":"73","author":"Hom","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2025.04.020_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1108\/14777260310469319","article-title":"Delphi: Myths and Reality","volume":"17","author":"Mullen","year":"2003","journal-title":"J Health Organ Manag"},{"key":"10.1016\/j.dld.2025.04.020_bib0016","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2025.04.020_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doae006","article-title":"Gastro-esophageal diagnostic workup before bariatric surgery or endoscopic treatment for obesity: position statement of the International Society of Diseases of the Esophagus","volume":"37","author":"Visaggi","year":"2024","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0018","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.dld.2024.02.020","article-title":"The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis-Current Treatment and Monitoring","volume":"56","author":"de Bortoli","year":"2024","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2025.04.020_bib0019","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.dld.2024.02.020","article-title":"The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis-Current Treatment and Monitoring","volume":"56","author":"de Bortoli","year":"2024","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2025.04.020_bib0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/apt.16778","article-title":"Systematic review with meta-analysis: artificial intelligence in the diagnosis of oesophageal diseases","volume":"55","author":"Visaggi","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0021","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ueg2.12259","article-title":"Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for","volume":"10","author":"Savarino","year":"2022","journal-title":"Neurogastroenterology and Motility. United European Gastroenterol J"},{"key":"10.1016\/j.dld.2025.04.020_bib0022","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2023.05.010","article-title":"The development methods of official GRADE articles and requirements for claiming the use of GRADE \u2013 A statement by the GRADE guidance group","volume":"159","author":"Sch\u00fcnemann","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2025.04.020_bib0023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease","volume":"117","author":"Katz","year":"2022","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1016\/j.dld.2025.04.020_bib0024","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1572-0241.2005.00343.x","article-title":"Gastroesophageal Reflux Symptoms and Well-Being in a Random Sample of the General Population of a Swedish Community","volume":"101","author":"Wiklund","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0025","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1365-2036.2006.02952.x","article-title":"Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population - The Kalixanda study","volume":"23","author":"Ronkainen","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0026","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrgastro.2017.130","article-title":"Advances in the physiological assessment and diagnosis of GERD","volume":"14","author":"Savarino","year":"2017","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2025.04.020_bib0027","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2036.2007.03372.x","article-title":"Review article: the pathophysiology of gastro-oesophageal reflux disease","volume":"26","author":"Boeckxstaens","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13104","article-title":"Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group","volume":"29","author":"Gyawali","year":"2017","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0029","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12920","article-title":"Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometry","volume":"29","author":"Roman","year":"2017","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0030","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/nmo.12606","article-title":"Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD","volume":"27","author":"Tolone","year":"2015","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0031","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/nmo.12638","article-title":"Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value? Address for Correspondence","volume":"27","author":"Tolone","year":"2015","journal-title":"Neurogastroenterol Motil"},{"issue":"11","key":"10.1016\/j.dld.2025.04.020_bib0032","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1111\/j.1572-0241.2008.02119.x","article-title":"The Role of Nonacid Reflux in NERD: Lessons Learned From Impedence-pH Monitoring in 150 Patients Off Therapy","volume":"103","author":"Savarino","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0033","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/ajg.2009.670","article-title":"Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: Study using combined impedance-pH off therapy","volume":"105","author":"Savarino","year":"2010","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0034","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0035","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/gut.2009.200063","article-title":"Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study","volume":"59","author":"Dent","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0036","doi-asserted-by":"crossref","unstructured":"Fass R, Zerbib F, Prakash Gyawali C. Clinical Practice Update AGA Clinical Practice Update On Functional Heartburn: Expert Review 2020.","DOI":"10.1053\/j.gastro.2020.01.034"},{"key":"10.1016\/j.dld.2025.04.020_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-022-00356-8","article-title":"Achalasia","volume":"8","author":"Savarino","year":"2022","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1016\/j.dld.2025.04.020_bib0038","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.dld.2016.11.012","article-title":"Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE)","volume":"49","author":"de Bortoli","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2025.04.020_bib0039","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/apt.13718","article-title":"The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon","volume":"44","author":"Savarino","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0040","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820980860","article-title":"Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults","volume":"14","author":"Visaggi","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0041","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.cgh.2020.03.057","article-title":"Untangling Nonerosive Reflux Disease From Functional Heartburn","volume":"19","author":"Patel","year":"2021","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2025.04.020_bib0042","first-page":"354","article-title":"Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.dld.2025.04.020_bib0043","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/gutjnl-2023-330616","article-title":"Updates to the modern diagnosis of GERD: Lyon consensus 2.0","volume":"73","author":"Gyawali","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0044","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0016-5085(97)70168-9","article-title":"Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans","volume":"113","author":"el-Serag","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jvoice.2005.10.006","article-title":"Symptoms of Extraesophageal Reflux in a Community-Dwelling Sample","volume":"21","author":"Connor","year":"2007","journal-title":"Journal of Voice"},{"key":"10.1016\/j.dld.2025.04.020_bib0046","first-page":"640","article-title":"Chronic Cough: The Spectrum and Frequency of Causes, Key Components of the Diagnostic Evaluation, and Outcome of Specific Therapy","volume":"141","author":"Irwin","year":"2012","journal-title":"AJRCCM"},{"key":"10.1016\/j.dld.2025.04.020_bib0047","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.chest.2016.08.1458","article-title":"Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report","volume":"150","author":"Kahrilas","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.dld.2025.04.020_bib0048","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/gut.2007.122465","article-title":"The association between gastro-oesophageal reflux disease and asthma: a systematic review","volume":"56","author":"Havemann","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0049","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa0806290","article-title":"Efficacy of Esomeprazole for Treatment of Poorly Controlled Asthma","volume":"360","author":"Castro","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jama.2011.2035","article-title":"Lansoprazole for Children With Poorly Controlled Asthma: A Randomized Controlled Trial","volume":"307","author":"Holbrook","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2025.04.020_bib0051","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1164\/rccm.200808-1359OC","article-title":"Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma","volume":"179","author":"Savarino","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.dld.2025.04.020_bib0052","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00101212","article-title":"Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients","volume":"42","author":"Savarino","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.dld.2025.04.020_bib0053","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13001","article-title":"Lung disease severity in idiopathic pulmonary fibrosis is more strongly associated with impedance measures of bolus reflux than pH parameters of acid reflux alone","volume":"29","author":"Gavini","year":"2017","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0054","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2147\/TCRM.S184291","article-title":"Idiopathic pulmonary fibrosis and GERD: links and risks","volume":"15","author":"Ghisa","year":"2019","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.dld.2025.04.020_bib0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1164\/rccm.200808-1359OC","article-title":"Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring","volume":"179","author":"Savarino","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0056","doi-asserted-by":"crossref","first-page":"405","DOI":"10.14309\/ajg.0000000000001577","article-title":"Novel Advanced Impedance Metrics on Impedance-pH Testing Predict Lung Function Decline in Idiopathic Pulmonary Fibrosis","volume":"117","author":"Rangan","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0057","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0058","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.3748\/wjg.v18.i32.4363","article-title":"How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?","volume":"18","author":"de Bortoli","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0059","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.giec.2019.12.004","article-title":"Laryngopharyngeal Reflux and Atypical Gastroesophageal Reflux Disease","volume":"30","author":"Barrett","year":"2020","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.dld.2025.04.020_bib0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.14728","article-title":"An update on current treatment strategies for laryngopharyngeal reflux symptoms","volume":"1510","author":"Krause","year":"2022","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.dld.2025.04.020_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2022.01.025","article-title":"Clinical Practice Update AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review","volume":"20","author":"Yadlapati","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0062","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2016.02.012","article-title":"Esophageal Disorders","volume":"150","author":"Aziz","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0063","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.14309\/ajg.0000000000000754","article-title":"The Role of Symptom Association Analysis in Gastroesophageal Reflux Testing","volume":"115","author":"Kamal","year":"2020","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0064","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12947","article-title":"The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring","volume":"29","author":"Frazzoni","year":"2017","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0065","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/j.1572-0241.2008.02033.x","article-title":"Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: \u201con\u201d or \u201coff\u201d proton pump inhibitor?","volume":"103","author":"Hemmink","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2025.04.020_bib0066","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1053\/j.gastro.2021.07.004","article-title":"Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management","volume":"161","author":"Gyawali","year":"2021","journal-title":"Gastroenrerology"},{"key":"10.1016\/j.dld.2025.04.020_bib0067","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14177","article-title":"Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non-erosive reflux disease","volume":"33","author":"Losa","year":"2021","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0068","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14075","article-title":"ESNM\/ANMS consensus paper: Diagnosis and management of refractory gastro-esophageal reflux disease","volume":"33","author":"Zerbib","year":"2021","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0069","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MOG.0000000000000846","article-title":"Recent insights on functional heartburn and reflux hypersensitivity","volume":"38","author":"Savarino","year":"2022","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0070","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14056","article-title":"Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease","volume":"33","author":"Rengarajan","year":"2021","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.03.063","article-title":"Identification of Different Phenotypes of Esophageal Reflux Hypersensitivity and Implications for Treatment","volume":"19","author":"Sawada","year":"2021","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2025.04.020_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nmo.13067","article-title":"Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group","volume":"29","author":"Roman","year":"2017","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0073","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","article-title":"Modern diagnosis of GERD: the Lyon Consensus","volume":"67","author":"Prakash Gyawali","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0074","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10388-022-00933-6","article-title":"Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease","volume":"19","author":"Visaggi","year":"2022","journal-title":"Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cgh.2019.05.044","article-title":"Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring","volume":"18","author":"Rengarajan","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2025.04.020_bib0076","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1365-2982.2006.00825.x","article-title":"Ambulatory 24-h oesophageal impedance\u2013pH recordings: reliability of automatic analysis for gastro-oesophageal reflux assessment","volume":"18","author":"Roman","year":"2006","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0077","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5056\/jnm14075","article-title":"Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease","volume":"21","author":"Penagini","year":"2015","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2025.04.020_bib0078","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.14309\/ajg.0000000000000773","article-title":"Use of the Functional Lumen Imaging Probe in Clinical Esophagology","volume":"115","author":"Savarino","year":"2020","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0079","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/nmo.12457","article-title":"The diagnosis of gastro-esophageal reflux disease cannot be made with barium esophagograms","volume":"27","author":"Saleh","year":"2015","journal-title":"Neurogastroenterology & Motility"},{"issue":"10","key":"10.1016\/j.dld.2025.04.020_bib0080","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13861","article-title":"The role of ambulatory 24-hour esophageal manometry in clinical practice 2020","volume":"32","author":"Kamal","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2025.04.020_bib0081","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/nmo.12570","article-title":"Predictive value of routine esophageal high-resolution manometry for gastro-esophageal reflux disease","volume":"27","author":"van Hoeij","year":"2015","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0082","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.dld.2016.06.021","article-title":"Practice guidelines on the use of esophageal manometry \u2013 A GISMAD-SIGE-AIGO medical position statement","volume":"48","author":"Savarino","year":"2016","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2025.04.020_bib0083","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/bjs.5493","article-title":"Combined multichannel intraluminal impedance\u2013pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication","volume":"93","author":"Mainie","year":"2006","journal-title":"British Journal of Surgery"},{"key":"10.1016\/j.dld.2025.04.020_bib0084","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00535-012-0672-2","article-title":"Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn","volume":"48","author":"Savarino","year":"2013","journal-title":"J Gastroenterol"},{"issue":"10","key":"10.1016\/j.dld.2025.04.020_bib0085","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1111\/j.1572-0241.2005.50209.x","article-title":"Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and Appropriate Control Group","volume":"100","author":"Zentilin","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0086","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ajg.2010.476","article-title":"Refractory heartburn: Comparison of intercellular space diameter in documented GERD vs. Functional heartburn","volume":"106","author":"Vela","year":"2011","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0087","doi-asserted-by":"crossref","first-page":"816","DOI":"10.14309\/ajg.0000000000001064","article-title":"Utility of Routine Esophageal Biopsies in Patients With Refractory Reflux Symptoms","volume":"116","author":"Oude Nijhuis","year":"2021","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0088","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1811424","article-title":"Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn","volume":"381","author":"Spechler","year":"2019","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2025.04.020_bib0089","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/dote.12163","article-title":"Systematic review: questionnaires for assessment of gastroesophageal reflux disease","volume":"28","author":"Bolier","year":"2015","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0090","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/MCG.0000000000001300","article-title":"Development of a Preliminary Question Prompt List as a Communication Tool for Adults With Gastroesophageal Reflux Disease: A Modified Delphi Study","volume":"54","author":"Kamal","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0091","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.cgh.2012.06.030","article-title":"Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease","volume":"10","author":"Bytzer","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0092","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1365-2036.2009.04142.x","article-title":"Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care","volume":"30","author":"Jones","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0093","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0094","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejim.2016.10.007","article-title":"The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal","volume":"37","author":"Savarino","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00535-022-01861-z","article-title":"Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021","volume":"57","author":"Iwakiri","year":"2022","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0096","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/17474124.2022.2043744","article-title":"The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD)","volume":"16","author":"Al-Marhabi","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0097","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","volume":"2013","author":"Sigterman","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2025.04.020_bib0098","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0099","article-title":"Effectiveness and Tolerability of Different Recommended Doses of PPIs and H2RAs in GERD: Network Meta-Analysis and GRADE system","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2025.04.020_bib0100","article-title":"Medical treatments in the short term management of reflux oesophagitis","author":"Khan","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2025.04.020_bib0101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2036.1995.tb00347.x","article-title":"A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis","volume":"9","author":"Robinson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0102","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2982.2012.01888.x","article-title":"PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis","volume":"24","author":"Weijenborg","year":"2012","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0103","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14469","article-title":"Comparison of acid-lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta-Analysis","volume":"35","author":"Barberio","year":"2023","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0104","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1001\/jama.294.12.1534","article-title":"Evaluation and management of laryngopharyngeal reflux","volume":"294","author":"Ford","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2025.04.020_bib0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.amjoto.2016.01.008","article-title":"Evaluation of a laryngopharyngeal reflux management protocol","volume":"37","author":"Gupta","year":"2016","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.dld.2025.04.020_bib0106","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/014556131309200811","article-title":"A systematic review of proton-pump inhibitor therapy for laryngopharyngeal reflux","volume":"92","author":"Megwalu","year":"2013","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.dld.2025.04.020_bib0107","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/j.1572-0241.2006.00844.x","article-title":"Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials","volume":"101","author":"Qadeer","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0108","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2036.2006.03213.x","article-title":"Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease","volume":"25","author":"Gatta","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0109","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/lary.27591","article-title":"Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis","volume":"129","author":"Lechien","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.dld.2025.04.020_bib0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MCG.0000000000000324","article-title":"Proton Pump Inhibitor Therapy for the Treatment of Laryngopharyngeal Reflux: A Meta-Analysis of Randomized Controlled Trials","volume":"50","author":"Guo","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0111","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jvoice.2019.05.005","article-title":"Proton Pump Inhibitors for the Treatment of Laryngopharyngeal Reflux. A Systematic Review","volume":"34","author":"Spantideas","year":"2020","journal-title":"J Voice"},{"key":"10.1016\/j.dld.2025.04.020_bib0112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bmj.38677.559005.55","article-title":"Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux","volume":"332","author":"Chang","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2025.04.020_bib0113","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1164\/rccm.200507-1167OC","article-title":"Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial","volume":"173","author":"Kiljander","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0114","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1001\/jama.2020.21360","article-title":"Gastroesophageal Reflux Disease: A Review","volume":"324","author":"Maret-Ouda","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2025.04.020_bib0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0892-1997(02)00097-8","article-title":"Validity and reliability of the reflux symptom index (RSI)","volume":"16","author":"Belafsky","year":"2002","journal-title":"J Voice"},{"key":"10.1016\/j.dld.2025.04.020_bib0116","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1097\/01.mlg.0000184325.44968.b1","article-title":"Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope)","volume":"115","author":"Milstein","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.dld.2025.04.020_bib0117","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.mlg.0000192173.00498.ba","article-title":"Treatment of chronic posterior laryngitis with esomeprazole","volume":"116","author":"Vaezi","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.dld.2025.04.020_bib0118","article-title":"Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults","volume":"2011","author":"Chang","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2025.04.020_bib0119","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1378\/chest.12-1788","article-title":"Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease","volume":"143","author":"Kahrilas","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.dld.2025.04.020_bib0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2036.2010.04511.x","article-title":"Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study","volume":"33","author":"Shaheen","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0121","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.14309\/ajg.0000000000001389","article-title":"The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough","volume":"116","author":"Ribolsi","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0122","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/apt.12919","article-title":"Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough","volume":"40","author":"Ribolsi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0123","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1523-5378.2008.00624.x","article-title":"Helicobacter pylori and gastroesophageal reflux disease: a case-control study","volume":"13","author":"Corley","year":"2008","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2025.04.020_bib0124","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2036.1999.00460.x","article-title":"Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management","volume":"13","author":"O\u2019Connor","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1572-0241.2000.01758.x","article-title":"Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett\u2019s esophagus, Barrett\u2019s dysplasia, and Barrett\u2019s adenocarcinoma","volume":"95","author":"Weston","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0126","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0016-5085(98)70364-6","article-title":"The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease","volume":"115","author":"Vicari","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0127","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.cgh.2007.08.010","article-title":"Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis","volume":"5","author":"Rokkas","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0128","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ajg.2009.734","article-title":"Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis","volume":"105","author":"Yaghoobi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1523-5378.2011.00846.x","article-title":"Effects of Helicobacter pylori eradication on gastroesophageal reflux disease","volume":"16","author":"Qian","year":"2011","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2025.04.020_bib0130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","article-title":"Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa","volume":"118","author":"Klinkenberg-Knol","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0131","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2013the Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0132","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM199604183341603","article-title":"Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication","volume":"334","author":"Kuipers","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0133","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.gie.2015.02.021","article-title":"The role of endoscopy in the management of GERD","volume":"81","author":"Standards of Practice Committee","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2025.04.020_bib0134","doi-asserted-by":"crossref","first-page":"E768","DOI":"10.1503\/cmaj.190814","article-title":"Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease","volume":"192","author":"Groulx","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.dld.2025.04.020_bib0135","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1572-0241.2004.30066.x","article-title":"The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms","volume":"99","author":"Poelmans","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0136","doi-asserted-by":"crossref","first-page":"808","DOI":"10.7326\/0003-4819-157-11-201212040-00008","article-title":"Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians","volume":"157","author":"Shaheen","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0137","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.01.012","article-title":"High Diagnostic Yield of Abnormal Endoscopic Findings in the Evaluation of Laryngopharyngeal Reflux","volume":"22","author":"Krause","year":"2024","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2025.04.020_bib0138","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2016.5657","article-title":"Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes","volume":"315","author":"Dunbar","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.dld.2025.04.020_bib0139","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ajg.2015.322","article-title":"ACG Clinical Guideline: Diagnosis and Management of Barrett\u2019s Esophagus","volume":"11","author":"Shaheen","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0140","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00535-012-0672-2","article-title":"Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn","volume":"48","author":"Savarino","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0141","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5858\/2005-129-159-ITASOH","article-title":"Is there a set of histologic changes that are invariably reflux associated?","volume":"129","author":"Takubo","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0142","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13643-020-1275-2","volume":"9","author":"Hamel","year":"2020","journal-title":"Syst Rev"},{"key":"10.1016\/j.dld.2025.04.020_bib0143","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.gastro.2004.11.008","article-title":"American Gastroenterological Association. AGA technical review on the clinical use of esophageal manometry","volume":"128","author":"Pandolfino","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0144","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/BF01296558","article-title":"Gastroesophageal pH step-up inaccurately locates proximal border of lower esophageal sphincter","volume":"37","author":"Mattox","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2025.04.020_bib0145","first-page":"1463","article-title":"Esophageal 24-h pH monitoring: is prior manometry necessary for correct positioning of the electrode?","volume":"85","author":"Klauser","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0146","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00042737-200404000-00002","article-title":"pH probe positioning for 24-hour pH-metry by manometry or pH step-up","volume":"16","author":"Pehl","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0147","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1177\/2050640619860034","article-title":"Lower oesophageal sphincter identification for gastro-oesophageal reflux monitoring: The step-up method revisited with use of basal impedance","volume":"7","author":"Mauro","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.dld.2025.04.020_bib0148","doi-asserted-by":"crossref","first-page":"565","DOI":"10.5056\/jnm20158","article-title":"Patients With Definite and Inconclusive Evidence of Reflux According to Lyon Consensus Display Similar Motility and Esophagogastric Junction Characteristics","volume":"27","author":"Ribolsi","year":"2021","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2025.04.020_bib0149","article-title":"Fragmented and failed swallows on esophageal high-resolution manometry associate with abnormal reflux burden better than weak swallows","volume":"32","author":"Rogers","year":"2020","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0150","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13752","article-title":"Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients","volume":"32","author":"Ribolsi","year":"2020","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0151","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ueg2.12565","article-title":"The Milan score: A novel manometric tool for a more efficient diagnosis of gastro-esophageal reflux disease","volume":"12","author":"Siboni","year":"2024","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.dld.2025.04.020_bib0152","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1442-2050.2002.00229.x","article-title":"Preoperative esophageal body motility does not influence the outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease","volume":"15","author":"Booth","year":"2002","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0153","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s00464-012-2350-0","article-title":"The value of multiple rapid swallows during preoperative esophageal manometry before laparoscopic antireflux surgery","volume":"26","author":"Stoikes","year":"2012","journal-title":"Surg Endosc"},{"key":"10.1016\/j.dld.2025.04.020_bib0154","doi-asserted-by":"crossref","first-page":"447","DOI":"10.5056\/jnm19153","article-title":"High-resolution Manometry Determinants of Refractoriness of Reflux Symptoms to Proton Pump Inhibitor Therapy","volume":"26","author":"Ribolsi","year":"2020","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2025.04.020_bib0155","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/nmo.12620","article-title":"Patients with refractory reflux symptoms often do not have GERD","volume":"27","author":"Herregods","year":"2015","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0156","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1111\/j.1365-2982.2009.01431.x","article-title":"Rumination or belching-regurgitation? Differential diagnosis using oesophageal impedance-manometry","volume":"22","author":"Rommel","year":"2010","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0157","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gut.2003.033290","article-title":"Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux","volume":"53","author":"Sifrim","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0158","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2036.2008.03923.x","article-title":"Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies","volume":"29","author":"Sweis","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0159","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1572-0241.2006.00711.x","article-title":"Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy","volume":"101","author":"Zerbib","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0160","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1365-2036.2007.03529.x","article-title":"Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy","volume":"26","author":"Becker","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0161","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MCG.0b013e31818859a3","article-title":"Nonacid reflux episodes reaching the pharynx are important factors associated with cough","volume":"43","author":"Patterson","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0162","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/apt.12919","article-title":"Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough","volume":"40","author":"Ribolsi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0163","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s11605-008-0583-y","article-title":"Prospective assessment of patient selection for antireflux surgery by combined multichannel intraluminal impedance pH monitoring","volume":"12","author":"Del Genio","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0164","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ajg.2014.63","article-title":"Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters","volume":"109","author":"Patel","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0165","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s11695-016-2127-y","article-title":"High-resolution Impedance Manometry after Sleeve Gastrectomy: Increased Intragastric Pressure and Reflux are Frequent Events","volume":"26","author":"Mion","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0166","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.soard.2015.03.011","article-title":"Effects of omega-loop bypass on esophagogastric junction function","volume":"12","author":"Tolone","year":"2016","journal-title":"Surg Obes Relat Dis"},{"issue":"28 Suppl 1","key":"10.1016\/j.dld.2025.04.020_bib0167","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.ijsu.2015.12.047","article-title":"Esophagogastric junction morphology assessment by high resolution manometry in obese patients candidate to bariatric surgery","author":"Tolone","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0168","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/nyas.13107","article-title":"The impact of bariatric surgery on esophageal function","volume":"1381","author":"Tolone","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.dld.2025.04.020_bib0169","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.soard.2019.01.030","article-title":"Esophagogastric junction function and gastric pressure profile after minigastric bypass compared with Billroth II","volume":"15","author":"Tolone","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.dld.2025.04.020_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11605-019-04406-7","article-title":"Esophageal High-Resolution Manometry Can Unravel the Mechanisms by Which Different Bariatric Techniques Produce Different Reflux Exposures","volume":"24","author":"Tolone","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0171","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13020545","article-title":"De Novo Gastroesophageal Reflux Disease Symptoms Are Infrequent after Sleeve Gastrectomy at 2-Year Follow-Up Using a Comprehensive Preoperative Esophageal Assessment","volume":"13","author":"Tolone","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0172","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doae006","article-title":"Gastro-esophageal diagnostic workup before bariatric surgery or endoscopic treatment for obesity: position statement of the International Society of Diseases of the Esophagus","volume":"37","author":"Visaggi","year":"2024","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0173","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/ajg.2014.165","article-title":"The Pathophysiology, Diagnosis and Treatment of Excessive Belching Symptoms","volume":"109","author":"Kessing","year":"2014","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0174","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000006297","article-title":"The Role of High-Resolution Manometry Before and Following Antireflux Surgery: The Padova Consensus","volume":"281","author":"Salvador","year":"2025","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0175","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gutjnl-2020-322627","article-title":"Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world","volume":"70","author":"Sifrim","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0176","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.dld.2020.04.031","article-title":"A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring","volume":"52","author":"Savarino","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2025.04.020_bib0177","first-page":"385","article-title":"Radiological examinations in the morpho-functional evaluation of the esophago-gastric junction in gastro-esophageal reflux disease","volume":"104","author":"Brusori","year":"2002","journal-title":"Radiol Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0178","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/radiology.147.1.6828761","article-title":"The role of single and double-contrast radiography in the diagnosis of reflux esophagitis","volume":"147","author":"Creteur","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2025.04.020_bib0179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01893061","article-title":"Significance of diffuse granularity and nodularity of the esophageal mucosa at double-contrast radiography","volume":"10","author":"Graziani","year":"1985","journal-title":"Gastrointest Radiol"},{"key":"10.1016\/j.dld.2025.04.020_bib0180","doi-asserted-by":"crossref","DOI":"10.1007\/s00261-003-0128-5","article-title":"Detection of reflux esophagitis on double-contrast esophagrams and endoscopy using the histologic findings as the gold standard","volume":"29","author":"Dibble","year":"2004","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.dld.2025.04.020_bib0181","first-page":"346","article-title":"Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study","volume":"27","author":"Inoue","year":"2014","journal-title":"Annals of Gastroenterology\u202f: Quarterly Publication of the Hellenic Society of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0182","doi-asserted-by":"crossref","first-page":"E443","DOI":"10.1055\/s-0044-101453","article-title":"Initial experience with a novel resection and plication (RAP) method for acid reflux: a pilot study","volume":"6","author":"Benias","year":"2018","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.dld.2025.04.020_bib0183","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s11605-019-04115-1","article-title":"First Experience with Banded Anti-reflux Mucosectomy (ARMS) for GERD: Feasibility, Safety, and Technique (with Video)","volume":"23","author":"Hedberg","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0184","unstructured":"National Institute for Care and Health Excellence. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. www.nice.org.uk\/guidance\/cg184. ISBN: 978-1-4731-0717-5."},{"key":"10.1016\/j.dld.2025.04.020_bib0185","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.dld.2020.11.022","article-title":"Systematic assessment of environmental factors for gastroesophageal reflux disease: An umbrella review of systematic reviews and meta-analyses","volume":"53","author":"Cheng","year":"2021","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2025.04.020_bib0186","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13009","article-title":"Weight loss and waist reduction is associated with improvement in gastroesophageal disease reflux symptoms: A longitudinal study of 15 295 subjects undergoing health checkups","volume":"29","author":"Park","year":"2017","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0187","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/dote.12319","article-title":"Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study","volume":"29","author":"de Bortoli","year":"2016","journal-title":"Diseases of the Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0188","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/dote.12384","article-title":"Adherence to a predominantly Mediterranean diet decreases the risk of gastroesophageal reflux disease: a cross-sectional study in a South Eastern European population","volume":"29","author":"Mone","year":"2016","journal-title":"Diseases of the Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0189","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7572430","article-title":"Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn","volume":"2018","author":"Martinucci","year":"2018","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.dld.2025.04.020_bib0190","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/TCRM.S296680","article-title":"Dietary and Lifestyle Factors Related to Gastroesophageal Reflux Disease: A Systematic Review","volume":"17","author":"Zhang","year":"2021","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.dld.2025.04.020_bib0191","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3746\/pnf.2021.26.4.367","article-title":"Dietary Intake in Relation to the Risk of Reflux Disease: A Systematic Review","volume":"26","author":"Heidarzadeh-Esfahani","year":"2021","journal-title":"Prev Nutr Food Sci"},{"key":"10.1016\/j.dld.2025.04.020_bib0192","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s10620-020-06414-z","article-title":"Study Group for the Evaluation of GERD Triggering Foods. Elimination of Dietary Triggers Is Successful in Treating Symptoms of Gastroesophageal Reflux Disease","volume":"66","author":"Tosetti","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2025.04.020_bib0193","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamainternmed.2020.7238","article-title":"Association of Diet and Lifestyle With the Risk of Gastroesophageal Reflux Disease Symptoms in US Women","volume":"181","author":"Mehta","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0194","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1017\/S1368980021000197","article-title":"Diet and risk of gastro-oesophageal reflux disease in the Melbourne Collaborative Cohort Study","volume":"24","author":"Wang","year":"2021","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.dld.2025.04.020_bib0195","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12875-021-01369-0","article-title":"Head of bed elevation to relieve gastroesophageal reflux symptoms: a systematic review","volume":"22","author":"Albarqouni","year":"2021","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.dld.2025.04.020_bib0196","doi-asserted-by":"crossref","first-page":"346","DOI":"10.14309\/ajg.0000000000001588","article-title":"Associations Between Sleep Position and Nocturnal Gastroesophageal Reflux: A Study Using Concurrent Monitoring of Sleep Position and Esophageal pH and Impedance","volume":"117","author":"Schuitenmaker","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dow020","article-title":"Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis","volume":"30","author":"Leiman","year":"2017","journal-title":"Diseases of the Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0198","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","volume":"2013","author":"Sigterman","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2025.04.020_bib0199","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/nyas.13169","article-title":"Between GERD and NERD: the relevance of weakly acidic reflux","volume":"1380","author":"de Bortoli","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.dld.2025.04.020_bib0200","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/17512433.2020.1752664","article-title":"Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease","volume":"13","author":"Savarino","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.dld.2025.04.020_bib0201","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.dld.2020.10.003","article-title":"Esophageal reflux hypersensitivity: Non-GERD or still GERD?","volume":"52","author":"Savarino","year":"2020","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2025.04.020_bib0202","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/gut.2011.241307","article-title":"Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease","volume":"60","author":"Kahrilas","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0203","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.cgh.2006.09.013","article-title":"Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials","volume":"4","author":"Gralnek","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0204","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00228-008-0576-5","article-title":"Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH","volume":"65","author":"Kirchheiner","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dld.2025.04.020_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.09.033","article-title":"Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency","volume":"16","author":"Graham","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0206","first-page":"24","article-title":"Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI","author":"Graham","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2025.04.020_bib0207","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archinternmed.2011.116","article-title":"The efficacy of proton pump inhibitors for the treatment of asthma in adults: a meta-analysis","volume":"171","author":"Chan","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0208","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1378\/chest.12-1788","article-title":"Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease","volume":"143","author":"Kahrilas","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.dld.2025.04.020_bib0209","first-page":"49","article-title":"Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux","author":"Liu","year":"2016","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"10.1016\/j.dld.2025.04.020_bib0210","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/lary.27591","article-title":"Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis","volume":"129","author":"Lechien","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.dld.2025.04.020_bib0211","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MCG.0000000000000324","article-title":"Proton Pump Inhibitor Therapy for the Treatment of Laryngopharyngeal Reflux: A Meta-Analysis of Randomized Controlled Trials","volume":"50","author":"Guo","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0212","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2021.12.247","article-title":"AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review","volume":"162","author":"Targownik","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0213","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1572-0241.2007.01106.x","article-title":"The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use","volume":"102","author":"Targownik","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0214","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1111\/j.1572-0241.2007.01509.x","article-title":"Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion","volume":"102","author":"Metz","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0215","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1365-2036.2012.05047.x","article-title":"Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers","volume":"35","author":"Chen","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0216","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0217","doi-asserted-by":"crossref","first-page":"m4903","DOI":"10.1136\/bmj.m4903","article-title":"Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial","author":"O\u2019Hara","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2025.04.020_bib0218","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/j.1572-0241.2003.07665.x","article-title":"Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs","volume":"98","author":"Inadomi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0219","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2147\/DDDT.S306371","article-title":"Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art","volume":"15","author":"Savarino","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0220","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cgh.2011.07.008","article-title":"Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease","volume":"10","author":"Hungin","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2025.04.020_bib0221","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-3565(05)00860-8","article-title":"Treatment of Patients With Persistent Heartburn Symptoms: A Double-Blind, Randomized Trial","volume":"4","author":"Fass","year":"2006","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2025.04.020_bib0222","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1046\/j.1365-2036.2000.00882.x","article-title":"Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-ce","volume":"14","author":"Fass","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0223","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/ajg.2010.368","article-title":"The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS\u2014A Cluster-Randomized Trial","volume":"105","author":"Moayyedi","year":"2010","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0224","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/11530810-000000000-00000","article-title":"Patient Satisfaction with Switching to Esomeprazole from Existing Proton Pump Inhibitor Therapy for Gastro-Oesophageal Reflux Disease","volume":"29","author":"Hoogendoorn","year":"2009","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.dld.2025.04.020_bib0225","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.12659\/MSM.895346","article-title":"Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life","volume":"21","author":"Takeshima","year":"2015","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.dld.2025.04.020_bib0226","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14075","article-title":"ESNM\/ANMS consensus paper: Diagnosis and management of refractory gastro-esophageal reflux disease","volume":"33","author":"Zerbib","year":"2021","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0227","first-page":"1","article-title":"A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease","volume":"30","author":"Hillman","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0228","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.phrs.2008.09.016","article-title":"Proton pump inhibitors in GORDAn overview of their pharmacology, efficacy and safety","volume":"59","author":"Savarino","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dld.2025.04.020_bib0229","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/j.1572-0241.2003.08783.x","article-title":"Gastric Acid Control With Esomeprazole, Lansoprazole, Omeprazole, Pantoprazole, and Rabeprazole: A Five-Way Crossover Study","volume":"98","author":"Miner","year":"2003","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0230","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0149-2918(01)80087-4","article-title":"Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials","volume":"23","author":"Caro","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0231","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.09.013","article-title":"Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial","volume":"160","author":"Yadlapati","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0232","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2036.1997.00167.x","article-title":"Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials","volume":"11","author":"Carlsson","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0233","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5056\/jnm21095","article-title":"On-demand Versus Continuous Maintenance Treatment of Gastroesophageal Reflux Disease With Proton Pump Inhibitors: A Systematic Review and Meta-analysis","volume":"28","author":"Kang","year":"2022","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2025.04.020_bib0234","first-page":"1","article-title":"The natural history of gastro-esophageal reflux disease: a comprehensive review","volume":"30","author":"Savarino","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0235","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133162","article-title":"Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence","volume":"13","author":"Visaggi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.dld.2025.04.020_bib0236","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/gutjnl-2013-305997","article-title":"Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett\u2019s oesophagus: a systematic review and meta-analysis","volume":"63","author":"Singh","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0237","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1007\/s00432-021-03544-3","article-title":"Do proton pump inhibitors prevent Barrett\u2019s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis","volume":"147","author":"Chen","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.dld.2025.04.020_bib0238","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrgastro.2013.50","article-title":"NERD: an umbrella term including heterogeneous subpopulations","volume":"10","author":"Savarino","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0239","article-title":"Deprescribing versus continuation of chronic proton pump inhibitor use in adults","volume":"3","author":"Boghossian","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2025.04.020_bib0240","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6417526","article-title":"On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis","volume":"2018","author":"Khan","year":"2018","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.dld.2025.04.020_bib0241","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0242","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/apt.13324","article-title":"Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology","volume":"42","author":"Lundell","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0243","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2012-1548","article-title":"Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects","volume":"97","author":"Mosli","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dld.2025.04.020_bib0244","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000091298","article-title":"Acid Suppression Therapy: Where Do We Go from Here?","volume":"24","author":"Scarpignato","year":"2006","journal-title":"Digestive Diseases"},{"key":"10.1016\/j.dld.2025.04.020_bib0245","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.3748\/wjg.v11.i26.4067","article-title":"Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis","volume":"11","author":"Wang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0246","article-title":"Medical treatments in the short term management of reflux oesophagitis","author":"Khan","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2025.04.020_bib0247","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1572-0241.1998.221_a.x","article-title":"Nocturnal Recovery of Gastric Acid Secretion With Twice-Daily Dosing of Proton Pump Inhibitors","volume":"93","author":"Peghini","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0248","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/MCG.0b013e31814a4e5c","article-title":"Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough","volume":"42","author":"Mainie","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0249","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1442-2050.2005.00518.x","article-title":"Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy","volume":"18","author":"Rackoff","year":"2005","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0250","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/phar.2899","article-title":"Acid-suppressive drugs: A systematic review and network meta-analysis of their nocturnal acid-inhibitory effect","volume":"44","author":"Zou","year":"2024","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.dld.2025.04.020_bib0251","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1442-2050.2005.00518.x","article-title":"Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy","volume":"18","author":"Rackoff","year":"2005","journal-title":"Diseases of the Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0252","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/gast.2002.31876","article-title":"Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough","volume":"122","author":"Fackler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0253","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2050640612473964","article-title":"Modern medical and surgical management of difficult-to-treat GORD","volume":"1","author":"Zerbib","year":"2013","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.dld.2025.04.020_bib0254","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3748\/wjg.v20.i9.2412","article-title":"Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis","volume":"20","author":"Ren","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0255","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3748\/wjg.v26.i19.2333","article-title":"Gastroparesis: New insights into an old disease","volume":"26","author":"Usai-Satta","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0256","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10388-020-00753-6","article-title":"The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis","volume":"18","author":"Xi","year":"2021","journal-title":"Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0257","doi-asserted-by":"crossref","first-page":"9111","DOI":"10.3748\/wjg.v19.i47.9111","article-title":"Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: A systematic review","volume":"19","author":"Liu","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0258","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/apt.13115","article-title":"Randomised clinical trial: the 5- HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy","volume":"41","author":"Shaheen","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0259","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/nmo.12484","article-title":"Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment","volume":"27","author":"Tack","year":"2015","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0260","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1752-1947-8-34","article-title":"Prucalopride reduces the number of reflux episodes and improves subjective symptoms in gastroesophageal reflux disease: a case series","volume":"8","author":"Nennstiel","year":"2014","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.dld.2025.04.020_bib0261","first-page":"233","article-title":"Combination of PPI with a prokinetic drug in gastroesophageal reflux disease","volume":"43","author":"Ndraha","year":"2011","journal-title":"Acta Med Indones"},{"key":"10.1016\/j.dld.2025.04.020_bib0262","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000198476","article-title":"Domperidone: a Drug with Powerful Action on the Lower Esophageal Sphincter Pressure","volume":"20","author":"Bron","year":"1980","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2025.04.020_bib0263","article-title":"Prokinetics for functional dyspepsia","volume":"10","author":"Pittayanon","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2025.04.020_bib0264","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4103\/ijmr.IJMR_1039_17","article-title":"Prescription pattern & adverse drug reactions of prokinetics","volume":"149","author":"Biswas","year":"2019","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.dld.2025.04.020_bib0265","unstructured":"Nota Informativa Importante AIFA sui medicinali a base di domperidone. https:\/\/www.aifa.gov.it\/-\/nota-informativa-importante-aifa-sui-medicinali-a-base-di-domperidone (accessed April 1, 2025)."},{"key":"10.1016\/j.dld.2025.04.020_bib0266","unstructured":"Metoclopramide: modificate le indicazioni e dosi e tempi di assunzione. https:\/\/www.aifa.gov.it\/-\/metoclopramide-modificate-le-indicazioni-e-dosi-e-tempi-di-assunzione (accessed April 1, 2025)."},{"key":"10.1016\/j.dld.2025.04.020_bib0267","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/827989","article-title":"The Effects of Baclofen for the Treatment of Gastroesophageal Reflux Disease: A Meta-Analysis of Randomized Controlled Trials","volume":"2014","author":"Li","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.dld.2025.04.020_bib0268","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1811424","article-title":"Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn","volume":"381","author":"Spechler","year":"2019","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2025.04.020_bib0269","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gut.52.4.464","article-title":"Effect of acute and chronic administration of the GABAB agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease","volume":"52","author":"Ciccaglione","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0270","article-title":"Efficacy of Baclofen as Add-on Therapy for Refractory Gastroesophageal Reflux Disease: A Meta-analysis","author":"Dong","year":"2024","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0271","first-page":"10","article-title":"Baclofen as a therapeutic option for gastroesophageal reflux disease: A systematic review of clinical trials","author":"Arabpour","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.dld.2025.04.020_bib0272","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5056\/jnm18029","article-title":"Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases","volume":"24","author":"Oshima","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2025.04.020_bib0273","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/17474124.2021.1984878","article-title":"An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders","volume":"16","author":"Savarino","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0274","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/17425255.2016.1214714","article-title":"Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations","volume":"12","author":"Savarino","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.dld.2025.04.020_bib0275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11894-024-00939-3","article-title":"Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments","volume":"26","author":"Scarpignato","year":"2024","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.dld.2025.04.020_bib0276","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10620-020-06141-5","article-title":"Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis","volume":"66","author":"Cheng","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2025.04.020_bib0277","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/jgh.14664","article-title":"Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review","volume":"34","author":"Miyazaki","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0278","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.gastro.2022.09.041","article-title":"Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial","volume":"164","author":"Laine","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0279","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.05.004","article-title":"Vonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial","volume":"22","author":"Laine","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0280","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/apt.17728","article-title":"Randomised clinical trial: Efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux disease","volume":"58","author":"Fass","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0281","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/apt.15185","article-title":"Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis","volume":"49","author":"Lee","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0282","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/apt.16477","article-title":"Randomised clinical trial: comparison of tegoprazan and placebo in non-erosive reflux disease","volume":"54","author":"Kim","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0283","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5056\/jnm21077","article-title":"2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease","volume":"27","author":"Jung","year":"2021","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2025.04.020_bib0284","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s00535-019-01572-y","article-title":"Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease","volume":"54","author":"Miwa","year":"2019","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0285","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5056\/jnm21077","article-title":"2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease","volume":"27","author":"Jung","year":"2021","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2025.04.020_bib0286","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/1751-2980.13028","article-title":"Chinese expert consensus on gastroesophageal reflux disease in 2020","volume":"22","author":"Xiao","year":"2021","journal-title":"J Dig Dis"},{"key":"10.1016\/j.dld.2025.04.020_bib0287","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00535-022-01861-z","article-title":"Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021","volume":"57","author":"Iwakiri","year":"2022","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0288","first-page":"121","article-title":"Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda","volume":"89","author":"Valdovinos D\u00edaz","year":"2024","journal-title":"Revista de Gastroenterologia de Mexico (English)"},{"key":"10.1016\/j.dld.2025.04.020_bib0289","doi-asserted-by":"crossref","first-page":"68","DOI":"10.59556\/japi.73.0844","article-title":"Association of Physicians of India Consensus Recommendations for Vonoprazan in Management of Acid Peptic Disorders","volume":"73","author":"Upadhyay","year":"2025","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.dld.2025.04.020_bib0290","article-title":"Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies","author":"Tran","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0291","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00365528909093066","article-title":"Symptomatic Effect of a Low-Dose Antacid Regimen in Reflux Oesophagitis","volume":"24","author":"Weberg","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0292","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(74)92340-X","article-title":"Alginate\/Antacid In The Reduction Of Gastro-Oesophageal Reflux","volume":"303","author":"Stanciu","year":"1974","journal-title":"The Lancet"},{"key":"10.1016\/j.dld.2025.04.020_bib0293","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00045391-199505000-00003","article-title":"Self-Directed Treatment of Intermittent Heartburn: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Evaluation of Antacid and Low Doses of an H(2)-Receptor Antagonist (Famotidine)","volume":"2","author":"Simon","year":"1995","journal-title":"Am J Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0294","unstructured":"Korn S, Murakami A, Stauffer L, Tipping R. A Controlled Comparison of Symptom Relief Provided by a Famotidine\/Antacid Combination Tablet for the Treatment of Frequent Heartburn. Data on File of Merck Research Laboratories, New Jersey, USA."},{"key":"10.1016\/j.dld.2025.04.020_bib0295","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1185\/03007999909114086","article-title":"A Comparison of the Efficacy of the Alginate Preparation, Gaviscon Advance, with Placebo in the Treatment of Gastro-Oesophageal Reflux Disease","volume":"15","author":"Chatfieid","year":"1999","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.dld.2025.04.020_bib0296","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1185\/03007997209111146","article-title":"Medical treatment of symptomatic hiatus hernia with low-density compounds","volume":"1","author":"Beeley","year":"1972","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.dld.2025.04.020_bib0297","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00007611-198603000-00017","article-title":"Effectiveness of Foaming Antacid in Relieving Induced Heartburn","volume":"79","author":"Fl","year":"1986","journal-title":"South Med J"},{"key":"10.1016\/j.dld.2025.04.020_bib0298","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.0953-0673.1996.00441.x","article-title":"Sucralfate gel versus placebo in patients with non-erosive gastro- oesophageal reflux disease","volume":"10","author":"Simon","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0299","first-page":"1335","article-title":"Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux","volume":"85","author":"Herrera","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0300","series-title":"Cochrane Database of Systematic Reviews","article-title":"Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease","author":"Donnellan","year":"2004"},{"key":"10.1016\/j.dld.2025.04.020_bib0301","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12664-019-00979-y","article-title":"Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology","volume":"38","author":"Bhatia","year":"2019","journal-title":"Indian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0302","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2036.2000.00759.x","article-title":"Review article: alginate-raft formulations in the treatment of heartburn and acid reflux","volume":"14","author":"Mandel","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0303","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2036.2011.04678.x","article-title":"An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial \u2018acid pocket\u2019 in symptomatic GERD patients","volume":"34","author":"Kwiatek","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0304","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/apt.15884","article-title":"Duration of adhesion of swallowed alginates to distal oesophageal mucosa: implications for topical therapy of oesophageal diseases","volume":"52","author":"Sonmez","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2036.2004.02298.x","article-title":"An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry","volume":"21","author":"Zentilin","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0306","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/apt.12482","article-title":"Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease","volume":"38","author":"Chiu","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0307","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/apt.14064","article-title":"Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms","volume":"45","author":"Coyle","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0308","doi-asserted-by":"crossref","first-page":"642","DOI":"10.5009\/gnl18378","article-title":"The Clinical Efficacy of a Pure Alginate Formulation (Lamina G) for Controlling Symptoms in Individuals with Reflux Symptoms: A Randomized Clinical Study","volume":"13","author":"Kim","year":"2019","journal-title":"Gut Liver"},{"key":"10.1016\/j.dld.2025.04.020_bib0309","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/apt.13567","article-title":"Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor","volume":"43","author":"Reimer","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0310","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1442-2050.2011.01276.x","article-title":"Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial","volume":"25","author":"Manabe","year":"2012","journal-title":"Diseases of the Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0311","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.3748\/wjg.v18.i32.4371","article-title":"Alginate controls heartburn in patients with erosive and nonerosive reflux disease","volume":"18","author":"Savarino","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0312","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3748\/wjg.v12.i5.747","article-title":"Prospective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease","volume":"12","author":"Lai","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0313","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00535-012-0672-2","article-title":"Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn","volume":"48","author":"Savarino","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0314","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cgh.2015.06.026","article-title":"Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease","volume":"14","author":"Frazzoni","year":"2016","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2025.04.020_bib0315","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00535-016-1226-9","article-title":"Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn","volume":"52","author":"Frazzoni","year":"2017","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0316","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.11.035","article-title":"Association Between Baseline Impedance Values and Response Proton Pump Inhibitors in Patients With Heartburn","volume":"13","author":"de Bortoli","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"6","key":"10.1016\/j.dld.2025.04.020_bib0317","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/gutjnl-2021-325531","article-title":"Application of Lyon Consensus criteria for GORD diagnosis: evaluation of conventional and new impedance-pH parameters","volume":"71","author":"Frazzoni","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0318","doi-asserted-by":"crossref","DOI":"10.20524\/aog.2017.0187","article-title":"Drugs for improving esophageal mucosa defense: where are we now and where are we going?","author":"Savarino","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0319","first-page":"43","article-title":"A chondroitin sulphate and hyaluronic acid-based dietary formulation improves non-erosive gastroesophageal reflux disease-related symptoms and gastric juice-related biochemical parameters: an open-label uncontrolled study","volume":"1","author":"Iannitti","year":"2017","journal-title":"Adv Health Dis"},{"key":"10.1016\/j.dld.2025.04.020_bib0320","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/CEG.S31404","article-title":"Barrier effect of Esoxx® on esophageal mucosal damage: experimental study on ex-vivo swine model","author":"Di Simone","year":"2012","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0321","first-page":"219","article-title":"Preliminary clinical experience with a new natural compound in the treatment of esophagitis and gastritis: symptomatic effect","author":"Palmieri","year":"2009","journal-title":"Trends Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0322","first-page":"3272","article-title":"Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo controlled study for the treatment of symptoms in patients with non-erosive gastroesophageal reflux","volume":"17","author":"Palmieri","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.dld.2025.04.020_bib0323","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/apt.13914","article-title":"Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease \u2013 efficacy of Esoxx, a hyaluronic acid\u2013chondroitin sulphate based bioadhesive formulation","volume":"45","author":"Savarino","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0324","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5152\/tjg.2020.19327","article-title":"Symptomatic response to GERDOFF\u00ae in patients with gastro-esophageal reflux disease and poor response to alginates: an exploratory, post-market, open-label study","volume":"31","author":"Boarino","year":"2020","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110752","article-title":"Protective and regenerative effects of a novel medical device against esophageal mucosal damage using in vitro and ex vivo models","volume":"131","author":"Agostinis","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.dld.2025.04.020_bib0326","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MEG.0000000000001888","article-title":"A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptoms","volume":"32","author":"Ribaldone","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0327","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.14309\/ajg.0000000000002360","article-title":"Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial","volume":"118","author":"Corazziari","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0328","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/apt.15604","article-title":"Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies","volume":"51","author":"Macke","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0329","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/gut.2007.127886","article-title":"Visceral hypersensitivity in non-erosive reflux disease","volume":"57","author":"Knowles","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0330","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/ajg.2009.670","article-title":"Characteristics of Reflux Episodes and Symptom Association in Patients With Erosive Esophagitis and Nonerosive Reflux Disease: Study Using Combined Impedance\u2013pH Off Therapy","volume":"105","author":"Savarino","year":"2010","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0331","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1111\/j.1572-0241.2008.02119.x","article-title":"The Role of Nonacid Reflux in NERD: Lessons Learned From Impedance-pH Monitoring in 150 Patients off Therapy","volume":"103","author":"Savarino","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0332","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/gut.2008.175810","article-title":"Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease","volume":"58","author":"Savarino","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.04.020_bib0333","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/ajg.2016.432","article-title":"Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD","volume":"111","author":"de Bortoli","year":"2016","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0334","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14056","article-title":"Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease","volume":"33","author":"Rengarajan","year":"2021","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0335","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14177","article-title":"Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non-erosive reflux disease","volume":"33","author":"Losa","year":"2021","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0336","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41395-018-0222-5","article-title":"Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis","volume":"114","author":"Ford","year":"2019","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0337","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.06.025","article-title":"Effects of Antidepressants in Patients With Functional Esophageal Disorders or Gastroesophageal Reflux Disease: A Systematic Review","volume":"13","author":"Weijenborg","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2025.04.020_bib0338","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ajg.2015.413","article-title":"Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: A Randomized Placebo-Controlled Trial","volume":"111","author":"Limsrivilai","year":"2016","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0339","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/ajg.2011.179","article-title":"Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-Blind, Placebo-Controlled Study","volume":"107","author":"Viazis","year":"2012","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0340","article-title":"Study on the Therapeutic Effects of Drug and Cognitive-Behavioral Therapy on Non-Erosive Reflux Disease Patients With Emotional Disorders","volume":"9","author":"Li","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.dld.2025.04.020_bib0341","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1365-2036.2007.03520.x","article-title":"Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn","volume":"26","author":"Dickman","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0342","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/dote.12353","article-title":"Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn","volume":"29","author":"Riehl","year":"2016","journal-title":"Diseases of the Esophagus"},{"key":"10.1016\/j.dld.2025.04.020_bib0343","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0889-8553(02)00065-1","article-title":"Gastroesophageal reflux disease during pregnancy","volume":"32","author":"Richter","year":"2003","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.dld.2025.04.020_bib0344","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2036.2005.02654.x","article-title":"Review article: the management of heartburn in pregnancy","volume":"22","author":"Richter","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0345","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2165\/00003495-199447020-00006","article-title":"Antacids: indications and limitations","volume":"47","author":"Ching","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2025.04.020_bib0346","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5694\/j.1326-5377.2005.tb06735.x","article-title":"Life-threatening milk-alkali syndrome resulting from antacid ingestion during pregnancy","volume":"182","author":"Gordon","year":"2005","journal-title":"Med J Aust"},{"key":"10.1016\/j.dld.2025.04.020_bib0347","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1742-1241.2003.tb10458.x","article-title":"An open-label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance) in the treatment of heartburn during pregnancy","volume":"57","author":"Lindow","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.dld.2025.04.020_bib0348","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/BF02088230","article-title":"Safety of first trimester exposure to histamine H2 blockers","volume":"41","author":"Magee","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2025.04.020_bib0349","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1023\/A:1015863018105","article-title":"Use of proton pump in-hibitors during pregnancy and rates of major malformations. A meta-analysis","volume":"47","author":"Nikfar","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2025.04.020_bib0350","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/clpt.1990.100","article-title":"Secretion of nizatidine into human breast milk after single and multiple doses","volume":"47","author":"Obermeyer","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0351","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/bfm.2018.0124","article-title":"Treating Gastroesophageal Reflux and Heartburn While Breastfeeding","volume":"13","author":"Anderson","year":"2018","journal-title":"Breastfeeding Medicine"},{"key":"10.1016\/j.dld.2025.04.020_bib0352","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s00268-011-1050-6","article-title":"Twenty Years of Laparoscopic Fundoplication for GERD","volume":"35","author":"Dallemagne","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0353","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/SLA.0b013e3181bcdaa7","article-title":"Ten-Year Outcome of Laparoscopic and Conventional Nissen Fundoplication","volume":"250","author":"Broeders","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0354","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjsurg.2012.10.032","article-title":"Late results after laparoscopic fundoplication denote durable symptomatic relief of gastroesophageal reflux disease","volume":"206","author":"Ross","year":"2013","journal-title":"The American Journal of Surgery"},{"key":"10.1016\/j.dld.2025.04.020_bib0355","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00464-005-0174-x","article-title":"Clinical results of laparoscopic fundoplication at ten years after surgery","volume":"20","author":"Dallemagne","year":"2006","journal-title":"Surgical Endoscopy And Other Interventional Techniques"},{"key":"10.1016\/j.dld.2025.04.020_bib0356","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/SLA.0b013e3182171c48","article-title":"Total or Posterior Partial Fundoplication in the Treatment of GERD","volume":"253","author":"Mardani","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0357","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/bjs.8870","article-title":"Twenty years of experience with laparoscopic antireflux surgery","volume":"99","author":"Engstr\u00f6m","year":"2012","journal-title":"British Journal of Surgery"},{"key":"10.1016\/j.dld.2025.04.020_bib0358","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00464-013-3140-z","article-title":"Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis","volume":"28","author":"Rickenbacher","year":"2014","journal-title":"Surg Endosc"},{"key":"10.1016\/j.dld.2025.04.020_bib0359","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003243.pub3","article-title":"Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults","volume":"2015","author":"Garg","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.dld.2025.04.020_bib0360","article-title":"A Meta-Analysis of Randomized Controlled Trials to Compare Long-Term Outcomes of Nissen and Toupet Fundoplication for Gastroesophageal Reflux Disease","volume":"10","author":"Tian","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2025.04.020_bib0361","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12876-016-0502-8","article-title":"A meta-analysis of long follow-up outcomes of laparoscopic Nissen (total) versus Toupet (270\u00b0) fundoplication for gastro-esophageal reflux disease based on randomized controlled trials in adults","volume":"16","author":"Du","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0362","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00268-014-2889-0","article-title":"Laparoscopic Anterior Versus Posterior Fundoplication for Gastro-esophageal Reflux Disease: A Meta-analysis and Systematic Review","volume":"39","author":"Memon","year":"2015","journal-title":"World J Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0363","doi-asserted-by":"crossref","first-page":"e8085","DOI":"10.1097\/MD.0000000000008085","article-title":"Laparoscopic Nissen (total) versus anterior 180\u00b0 fundoplication for gastro-esophageal reflux disease","volume":"96","author":"Du","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.dld.2025.04.020_bib0364","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s004640000392","article-title":"Obesity adversely affects the outcome of antireflux operations","volume":"15","author":"Perez","year":"2001","journal-title":"Surg Endosc"},{"key":"10.1016\/j.dld.2025.04.020_bib0365","doi-asserted-by":"crossref","DOI":"10.1136\/tsaco-2018-000219","article-title":"Early and late complications of bariatric operation","volume":"3","author":"Lim","year":"2018","journal-title":"Trauma Surg Acute Care Open"},{"key":"10.1016\/j.dld.2025.04.020_bib0366","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/lap.2007.0165","article-title":"Outcome of surgical fundoplication for extraesophageal (atypical) manifestations of gastroesophageal reflux disease in adults: a systematic review","volume":"18","author":"Iqbal","year":"2008","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"10.1016\/j.dld.2025.04.020_bib0367","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1007\/s00268-017-4058-8","article-title":"Surgical Treatment of Extraesophageal Manifestations of Gastroesophageal Reflux Disease","volume":"41","author":"Sidwa","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0368","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cgh.2016.10.031","article-title":"Association Between Response to Acid-Suppression Therapy and Efficacy of Antireflux Surgery in Patients With Extraesophageal Reflux","volume":"15","author":"Krill","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.020_bib0369","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ueg2.12318","article-title":"UEG and EAES rapid guideline: Update systematic review, network meta-analysis, CINeMA and GRADE assessment, and evidence-informed European recommendations on surgical management of GERD. United","volume":"10","author":"Markar","year":"2022","journal-title":"European Gastroenterol J"},{"key":"10.1016\/j.dld.2025.04.020_bib0370","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00464-014-3431-z","article-title":"EAES recommendations for the management of gastroesophageal reflux disease","volume":"28","author":"Fuchs","year":"2014","journal-title":"Surg Endosc"},{"key":"10.1016\/j.dld.2025.04.020_bib0371","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/SLA.0b013e3181fd879b","article-title":"Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial","volume":"252","author":"Bonavina","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2025.04.020_bib0372","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa1205544","article-title":"Esophageal sphincter device for gastroesophageal reflux disease","volume":"368","author":"Ganz","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2025.04.020_bib0373","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/nmo.12468","article-title":"The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients","volume":"27","author":"Rinsma","year":"2015","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.dld.2025.04.020_bib0374","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ajg.2015.28","article-title":"Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease","volume":"110","author":"Witteman","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0375","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1553350614526788","article-title":"Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial","volume":"22","author":"Trad","year":"2015","journal-title":"Surg Innov"},{"key":"10.1016\/j.dld.2025.04.020_bib0376","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.10.009","article-title":"Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial","volume":"148","author":"Hunter","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0377","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/apt.13427","article-title":"Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD","volume":"42","author":"Montgomery","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0378","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s00464-016-5111-7","article-title":"Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis","volume":"31","author":"Huang","year":"2017","journal-title":"Surg Endosc"},{"key":"10.1016\/j.dld.2025.04.020_bib0379","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00464-014-3731-3","article-title":"Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSETM) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial","volume":"29","author":"Zacherl","year":"2015","journal-title":"Surg Endosc"},{"key":"10.1016\/j.dld.2025.04.020_bib0380","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/den.12081","article-title":"Endoscopic stapling in comparison to laparoscopic fundoplication for the treatment of gastroesophageal reflux disease","volume":"26","author":"Danalioglu","year":"2014","journal-title":"Dig Endosc"},{"key":"10.1016\/j.dld.2025.04.020_bib0381","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ajg.2011.395","article-title":"A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD","volume":"107","author":"Arts","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.020_bib0382","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0016-5085(03)01052-7","article-title":"Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial","volume":"125","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.020_bib0383","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00464-009-0671-4","article-title":"A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease","volume":"24","author":"Abdel Aziz","year":"2010","journal-title":"Surg Endosc"},{"key":"10.1016\/j.dld.2025.04.020_bib0384","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1365-2036.2008.03790.x","article-title":"Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients","volume":"28","author":"Coron","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.020_bib0385","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1007\/s00464-017-5431-2","article-title":"Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease","volume":"31","author":"Fass","year":"2017","journal-title":"Surg Endosc"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825007303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825007303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T03:55:24Z","timestamp":1760154924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865825007303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":385,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1590865825007303"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2025.04.020","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG)","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2025.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}